Cutoff values of major surgical complications rates after gastrectomy

  • Gian Luca Baiocchi
  • Simone Giacopuzzi
  • Daniele Marrelli
Original Article
  • 41 Downloads
Part of the following topical collections:
  1. Gastric Cancer Surgery

Abstract

Gastric cancer is one of the most frequent cancers worldwide, and surgical resection remains the mainstay of the therapeutic pathway. Gastrectomy for cancer is still performed in many hospitals, and centralization remains limited to a small number of health systems. Morbidity and mortality after surgery for gastric cancer are surprisingly high. However, while mortality is obviously defined, major morbidity definitions still present some critical points. The aim of this study is to underline the need for universally accepted definitions of major complications and to describe the research agenda of a multicenter, European-based, prospective project launched by the European Chapter of the International Gastric Cancer Association (IGCA), with the goal of providing a list of complications related to gastrectomy for cancer with their definitions.

Keywords

Gastric cancer Gastrectomy Complications International consensus 

Notes

Compliance with ethical standards

Conflict of interest and source of funding

For all authors, none was declared.

Research involving human participants and/or animals

The current study does not involve human participants or animals. Hence, no Institutional Review Board’s prior approval was required.

Informed consent

The current study does not involve human participants. No informed consent was therefore necessary.

References

  1. 1.
    Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMedGoogle Scholar
  2. 2.
    Hartgrink HH, Jansen EP, van Grieken NC et al (2009) Gastric cancer. Lancet 374:477–490CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Pasquer A, Renaud F, Hec F, On behalf of the FREGAT Working Group—FRENCH et al (2016) Is centralization needed for esophageal and gastric cancer patients with low operative risk? A nationwide study. Ann Surg 264:823–830CrossRefPubMedGoogle Scholar
  4. 4.
    http://www.agenas.it Accessed 7 Nov 2016
  5. 5.
    Messager M, de Steur WO, van Sandick JW et al (2016) Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: a survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre). Eur J Surg Oncol 42:116–122CrossRefPubMedGoogle Scholar
  6. 6.
    Cuschieri A, Fayers P, Fielding J et al (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Surgical Cooperative Group. Lancet 347:995–999CrossRefPubMedGoogle Scholar
  7. 7.
    Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11–20CrossRefPubMedGoogle Scholar
  8. 8.
    Sano T, Sasako M, Yamamoto S et al (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group study 9501. J Clin Oncol 22:2767–2773CrossRefPubMedGoogle Scholar
  9. 9.
    Roviello F, Pedrazzani C, Marrelli D et al (2010) Super-extended (D3) lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol 36:439–446CrossRefPubMedGoogle Scholar
  10. 10.
    Bruce J, Russell EM, Mollison J et al (2001) The measurement and monitoring of surgical adverse events. Health Technol Assess 5:1–194CrossRefPubMedGoogle Scholar
  11. 11.
    Koch CG, Li L, Hixson E et al (2012) What are the real rates of postoperative complications: elucidating inconsistencies between administrative and clinical data sources. J Am Coll Surg 214:798–805CrossRefPubMedGoogle Scholar
  12. 12.
    Baiocchi GL, Giacopuzzi S, Marrelli D, Bencivenga M, Morgagni P, Rosa F, Berselli M, Orsenigo E, Cananzi F, Tiberio G, Rausei S, Cozzaglio L, Degiuli M, Di Leo A, Fumagalli U, Portolani N, Rosati R, Roviello F, De Manzoni G, Italian Research Group for Gastric Cancer (GIRCG) (2017) Complications after gastrectomy for cancer: Italian perspective. Updates Surg.  https://doi.org/10.1007/s13304-017-0478-0.pmid:28710718 Google Scholar
  13. 13.
    Wu Z, Wang Q, Shi J et al (2017) Diagnostic criteria and risk assessment of complications after gastric cancer surgery in western countries. Zhonghua Wei Chang Wai Ke Za Zhi 20:135–139PubMedGoogle Scholar
  14. 14.
    Wu Z, Li Z, Ji J (2017) Recognition of postoperative complication after surgery for gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 20:121–124PubMedGoogle Scholar
  15. 15.
    Cancer Therapy Evaluation Program NCI. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0; 2009Google Scholar
  16. 16.
    Clavien PA, Sanabria JR, Strasberg SM (1992) Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 111:518–526PubMedGoogle Scholar
  17. 17.
    Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Slankamenac K, Graf R, Barkun J et al (2013) The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg 258:1–7CrossRefPubMedGoogle Scholar
  19. 19.
    Clavien PA, Vetter D, Staiger R, Slankamenac K, Mehra T, Graf R, Puhan MA (2017) The comprehensive complication index (CCI®): added value and clinical perspectives 3 years down the line. Ann Surg 265:1045–1050CrossRefPubMedGoogle Scholar
  20. 20.
    Low DE, Alderson D, Cecconello I et al (2015) International consensus on standardization of data collection for complications associated with esophagectomy: esophagectomy complications consensus group (ECCG). Ann Surg 262:286–294CrossRefPubMedGoogle Scholar
  21. 21.
    Katayama H, Kurokawa Y, Nakamura K et al (2016) Extended Clavien–Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today 46:668–685CrossRefPubMedGoogle Scholar

Copyright information

© Italian Society of Surgery (SIC) 2018

Authors and Affiliations

  1. 1.Department of Clinical and Experimental Sciences, Surgical ClinicUniversity of BresciaBresciaItaly
  2. 2.General and Upper G.I. Surgery Division, Department of SurgeryUniversity of VeronaVeronaItaly
  3. 3.Unit of General Surgery and Surgical Oncology, Department of Medicine, Surgery and NeurosciencesUniversity of SienaSienaItaly

Personalised recommendations